| CISL2207 | BRIF | Retrospective analysis of opportunistic infectious events in Lymphoma patients who were treated with bendamustine plus anti-CD20 monoclonal antibody | Retrosp | B-NHL | 1st-line | | |
| CISL2103 | BIOPB | Impact of cell-of-origin and dual expression/translocation of MYC and BCL2/BCL6 on the risk of CNS relapse in patients with primary breast DLBCL: A multicenter, retrospective, biologic correlative study | Retrosp | DLBCL | Registry | | ASH초록: December 2022 oral and poster abstracts |
| CISL2001 | IBER | Clinical efficacy and safety of IBER salvage treatment followed by ibrutinib maintenance for transplant-ineligible patients with relapsed or refractory primary central nervous system lymphoma(PCNSL) | Phase 2 | CNS | Salvage | | |
| CISL1908 | COGETB | Prospective cohort study for genomic evaluation in patients with diffuse large B cell lymphoma after first relapse or progression (COGET-B) | Cohort | DLBCL | Registry | | 2023년 논문 작성중 |
| CISL1906 | KBPDCN | Blastic plasmacytoid dendritic cell neoplasm in Korean population: A multicenter study | Retrosp | BPDCN | Registry | | 2023년 후속연구 KBPDCN-gene와 함께 논문 작성 중
|
| CISL1903 | R2A | Phase II trial of Acalabrutinib with rituximab and lenalidomide in relapsed/refractory B-cell non-Hodgkin lymphoma | Phase 2 | B-NHL | Salvage | | 2023년 논문 작성중 |
| CISL1804 | RELOAD | Lenalidomide plus reduced dose R-CHOP chemotherapy followed by lenalidomide maintenance therapy in elderly patients with DLBCL | Phase 2 | DLBCL | 1st-line | | 연구시작을 못하고, 종료됨 |
| CISL1703 | PICASSO | Prospective randomized open-labeled phase III study comparing high-dose IV MTX versus IT MTX for the prophylaxis of CNS relapse in DLBCL | Phase 3 | DLBCL | 1st-line | | 2023년 최종 data 취합 예정 |
| CISL1701 | BIC | A Prospective, multi-center, open-label, single-arm, phase II study of bortezomib/dexamethasone therapy in patients with relapsed and/or refractory cutaneous T-cell lymphoma | Phase 2 | PTCL | Salvage | | 2023년 논문 작성중 |
| CISL1608 | SATURDAY | Phase 2 Study of Abbreviated 3 Cycles of Rituximab plus CHOP in Patients with Completely Excised Localized Gastrointestinal CD20 (+) Diffuse Large B-cell Lymphoma | Phase 2 | DLBCL | 1st-line | | 조기종료, CISL1209 중복 |
| CISL1604 | BATMAN | A Phase II trial to evaluate the efficacy of bortezomib, cytarabine, and dexamethasone in patients with relapsed or refractory mantle cell lymphoma | Phase 2 | MCL | Salvage | | 2023년 논문 작성중 |
| CISL1603 | IVAM | A phase II trial of ifosfamide, etoposide, cytarabine, and methotrexate (IVAM) chemotherapy for refractory or relapsed diffuse large B cell lymphoma | Phase 2 | DLBCL | Salvage | | 조기종료 |
| CISL1507 | BR_PTLD | Multicenter Phase II Study of Bendamustine Plus subcutaneous Rituximab in Patients with Diffuse Large B-cell Lymphoma (DLBCL) Type Monomorphic Post-transplant Lymphoproliferative Disorder (PTLD) | Phase 2 | PTLD | 1st-line | | 조기종료 |
| CISL1504 | ROSE | Randomized Phase II Study to Compare Efficacy of CHOP versus Fractionated ICED in Transplant-eligible Patients with Previously Untreated Peripheral T-cell Lymphoma | Phase 2 | PTCL | 1st-line | | 2023년 논문 작성중 |
| CISL1405 | Gastric MALT | Retrospective analysis of the Gastric MALT lymphoma patients who failed Helicobacter pylori eradication | Retrosp | MZL | | | PI 개인적으로 과제 진행, CISL에서 관리 진행 안함 (임성남) |
| CISL1401 | GI-FL | Clinical characteristics and outcomes of primary follicular lymphoma of the gastrointestinal tract according to the site of gastrointestinal tract: multicenter retrospective study | Retrosp | FL | | | 김진석_확인어려움 |
| CISL1210 | PBL | A multicenter retrospective study on clinicopathologic characteristics of Korean patients with plasmablastic lymphoma | Retrosp | NHL | | | CISL1508과 함께 논문 작성. publish 완료 |
| CISL1207 | MARCO | Hepatitis B virus reactivation in patients with marginal zone B-cell lymphoma after rituximab containing treatment: CISL MZL cohort study | Cohort | MZL | Registry | | 2022년 결과보고 완료. 논문 출판까지는 시간 오래 걸릴 것으로 예상(2023년) |
| CISL1007 | C.jejuni MZL | Relationship Between Intestinal Marginal Zone B-Cell Lymphoma and Enterobacterias Including Camphylobacter Jejuni | Retrosp | MZL | | | ASH 초록 : November 2011 Blood 118(21):5224-5224 |
| CISL1001 | PCNSL | Open-labeled, multicenter phase II study of HD MTX induction chemotherapy followed by alternative HD MTX-based and HD Cytarabine-based combination consolidation chemotherapy for newly diagnosed primary CNS lymphoma | Phase 2 | NHL | 1st-line | | 김진석 - 실종 |
| CISL0904 | ASCT | Retrospective analysis of effective conditioning regimens for autologous stem cell transplantation in NHL | Retrosp | NHL | | | 서철원 ? |
| CISL0803 | RR-CHOP | Open-labelled, Multicenter Phase II Study of Intensified 1st cycle Rituximab plus 8th cycles of R-CHOP Chemotherapy in Patients with Advanced or Bulky CD20+ DLBCL | Phase 2 | DLBCL | 1st-line | | 김진석 - 실종 |
|